Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Guideline
. 2022 Jul 1;42(4):391-397.
doi: 10.3343/alm.2022.42.4.391.

Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea

Ki Ho Hong  1 , Gab Jung Kim  2 , Kyoung Ho Roh  3 , Heungsup Sung  4 , Jaehyeon Lee  5 , So Yeon Kim  6 , Taek Soo Kim  7 , Jae-Sun Park  2 , Hee Jae Huh  8 , Younhee Park  1 , Jae-Seok Kim  9 , Hyun Soo Kim  9 , Moon-Woo Seong  7 , Nam Hee Ryoo  10 , Sang Hoon Song  7 , Hyukmin Lee  1 , Gye Cheol Kwon  11 , Cheon Kwon Yoo  2 ; COVID-19 Task Force, the Korean Society for Laboratory Medicine and the Bureau of Infectious Disease Diagnosis Control, the Korea Disease Control and Prevention Agency
Affiliations
Guideline

Update of Guidelines for Laboratory Diagnosis of COVID-19 in Korea

Ki Ho Hong et al. Ann Lab Med. .

Abstract

Korean Society for Laboratory Medicine and the Korea Disease Prevention and Control Agency have announced guidelines for diagnosing coronavirus disease (COVID-19) in clinical laboratories in Korea. With the ongoing pandemic, we propose an update of the previous guidelines based on new scientific data. This update includes recommendations for tests that were not included in the previous guidelines, including the rapid molecular test, antigen test, antibody test, and self-collected specimens, and a revision of the previous recommendations. This update will aid clinical laboratories in performing laboratory tests for diagnosing COVID-19.

Keywords: Antibody; Antigen; COVID-19; Guidelines; Laboratory diagnosis; Nasal swab; Pooled test; Rapid molecular test; SARS-CoV-2; Saliva.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST

None.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hong KH, Lee SW, Kim TS, Huh HJ, Lee J, Kim SY, et al. Guidelines for laboratory diagnosis of coronavirus disease 2019 (COVID-19) in Korea. Ann Lab Med. 2020;40:351–60. doi: 10.3343/alm.2020.40.5.351. - DOI - PMC - PubMed
    1. Kevadiya BD, Machhi J, Herskovitz J, Oleynikov MD, Blomberg WR, Bajwa N, et al. Diagnostics for SARS-CoV-2 infections. Nat Mater. 2021;20:593–605. doi: 10.1038/s41563-020-00906-z. - DOI - PMC - PubMed
    1. Au WY, Cheung PPH. Diagnostic performances of common nucleic acid tests for SARS-CoV-2 in hospitals and clinics: a systematic review and meta-analysis. Lancet Microbe. 2021;2:e704–14. doi: 10.1016/S2666-5247(21)00214-7. - DOI - PMC - PubMed
    1. Freije CA, Sabeti PC. Detect and destroy: CRISPR-based technologies for the response against viruses. Cell Host Microbe. 2021;29:689–703. doi: 10.1016/j.chom.2021.04.003. - DOI - PMC - PubMed
    1. Subali AD, Wiyono L. Reverse transcriptase loop mediated isothermal amplification (RT-LAMP) for COVID-19 diagnosis: a systematic review and meta-analysis. Pathog Glob Health. 2021;115:281–91. doi: 10.1080/20477724.2021.1933335. - DOI - PMC - PubMed

Publication types